These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35267621)

  • 1. Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV.
    Gerard JP; Myint AS; Barbet N; Dejean C; Thamphya B; Gal J; Montagne L; Vuong T
    Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
    Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP
    Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study.
    Mitrea D; Barbet N; Pacé-Loscos T; Scouarnec C; Ben-Dhia S; Baron D; Mineur L; Évesque L; Durand-Labrunie J; Gérard JP; Baudin G; Doyen J
    Cancer Radiother; 2024 Aug; 28(4):323-332. PubMed ID: 39003168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial.
    Gerard JP; Barbet N; Schiappa R; Magné N; Martel I; Mineur L; Deberne M; Zilli T; Dhadda A; Myint AS;
    Lancet Gastroenterol Hepatol; 2023 Apr; 8(4):356-367. PubMed ID: 36801007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence.
    Benezery K; Montagne L; Evesque L; Schiappa R; Hannoun-Levi JM; Francois E; Thamphya B; Gerard JP
    Clin Transl Radiat Oncol; 2020 Sep; 24():92-98. PubMed ID: 32695890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
    Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
    Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
    Sun Myint A; Rao C; Barbet N; Thamphya B; Pace-Loscos T; Schiappa R; Magné N; Martel-Lafay I; Mineur L; Deberne M; Zilli T; Dhadda A; Gerard JP
    Colorectal Dis; 2023 Nov; 25(11):2160-2169. PubMed ID: 37837240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.
    Sun Myint A; Smith FM; Gollins S; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman M; Pritchard DM
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):565-573. PubMed ID: 29229327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis.
    Steinke J; Jordan C; Rossides S; Minnaar H; Yu J; Franklin A; Rockall T; Dhadda AS; Andrew Hunter I; Mills J; Chadwick E; Silverman R; Folkesson J; Radu C; Myint AS; Stewart AJ
    Clin Transl Radiat Oncol; 2023 Mar; 39():100580. PubMed ID: 36686563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer.
    Gerard JP; Montagne L; Thamphya B; Doyen J; Schiappa R; Benezery K; Gourgou S; Dejean C; Hannoun-Levi JM
    Clin Transl Radiat Oncol; 2022 Mar; 33():70-76. PubMed ID: 35118202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence of Contact X-ray Brachytherapy (CXB) and External Beam Radiation (EBRT) in organ-preserving treatment for small rectal cancer.
    Than NW; Pritchard DM; Hughes DM; Duckworth CA; Wong H; Haq MU; Sripadam R; Myint AS
    Radiother Oncol; 2024 Oct; 199():110465. PubMed ID: 39074538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low energy contact X-ray brachytherapy for treatment of rectal cancer: a health technology appraisal by Health Technology Wales.
    Bennett H; Rao C; Batten L; Hasler E; Jarrom D; Prettyjohns M; Barrington C; Sun Myint A
    Colorectal Dis; 2024 May; 26(5):1053-1058. PubMed ID: 38467574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-centre analysis of adjuvant contact X-ray brachytherapy (CXB) in rectal cancer patients treated with local excision - Preliminary results of the CONTEM1 study.
    Dhadda A; Sun Myint A; Thamphya B; Hunter I; Hershman M; Gerard JP
    Radiother Oncol; 2021 Sep; 162():195-201. PubMed ID: 34329654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?
    Sun Myint A; Smith FM; Gollins SW; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman MJ; Fekete Z; Perkins K; Pritchard DM
    Br J Radiol; 2017 Dec; 90(1080):20170175. PubMed ID: 28937269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer.
    Stewart AJ; Van Limbergen EJ; Gerard JP; Appelt AL; Verhaegen F; Berbee M; Vuong T; Brooker C; Rockall T; Sun Myint A
    Clin Transl Radiat Oncol; 2022 Mar; 33():15-22. PubMed ID: 35243017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial.
    Ortholan C; Romestaing P; Chapet O; Gerard JP
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e165-71. PubMed ID: 22579379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contact X-ray brachytherapy (CXB) as a salvage treatment for rectal cancer patients who developed local tumor re-growth after watch-and-wait approach.
    Than NW; Pritchard DM; Duckworth CA; Hughes DM; Wong H; Sripadam R; Myint AS
    J Contemp Brachytherapy; 2024 Apr; 16(2):95-102. PubMed ID: 38808203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term control of T2-T3 rectal adenocarcinoma with radiotherapy alone.
    Gerard JP; Chapet O; Ramaioli A; Romestaing P
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):142-9. PubMed ID: 12182984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contact X-ray brachytherapy for rectal cancer: Past, present, and future.
    Gérard JP; Barbet N; Dejean C; Montagne L; Bénézery K; Coquard R; Doyen J; Durand Labrunie J; Hannoun-Lévi JM
    Cancer Radiother; 2021 Dec; 25(8):795-800. PubMed ID: 34052134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial.
    Gerard JP; Chapet O; Nemoz C; Hartweig J; Romestaing P; Coquard R; Barbet N; Maingon P; Mahe M; Baulieux J; Partensky C; Papillon M; Glehen O; Crozet B; Grandjean JP; Adeleine P
    J Clin Oncol; 2004 Jun; 22(12):2404-9. PubMed ID: 15197202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.